| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA303: Teriflunomide for treating relapsing–remitting multiple sclerosis |
|
Medicine details |
|
| Medicine name | teriflunomide (Aubagio®) |
| Formulation | 14 mg film-coated tablet |
| Reference number | 565 |
| Indication | Treatment of adult patients with relapsing-remitting multiple sclerosis |
| Company | Genzyme Therapeutics |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 14/06/2013 |
| NICE guidance | TA303: Teriflunomide for treating relapsing–remitting multiple sclerosis |